Updated Product Label Allows Home Administration of Omacetaxine Mepesuccinate

The U.S. Food and Drug Administration’s accelerated approval of omacetaxine mepesuccinate for the treatment of chronic-phase or accelerated-phase chronic myeloid leukemia has been converted to full approval. Approved changes to the omacetaxine administration guidelines to allow home administration u...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Oncologist
Hoofdauteurs: Shen, Ann Q., Munteanu, Mihaela, Khoury, Hanna Jean
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: AlphaMed Press 2014
Onderwerpen:
Letters to the Editor
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4221374/
https://ncbi.nlm.nih.gov/pubmed/25280490
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2014-0230
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items